Ovarian NeoplasmsPhase 3NCT00057720
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
A Phase 3 study testing TLK286 HCl for injection, topotecan hydrochloride for injection and doxorubicin HCl liposome injection in people with Ovarian Neoplasms, run by Telik at 320 sites in 13 countries.
Trial summary
The purpose of this study is to demonstrate superiority in survival in favor of TLK286 as compared to active control therapy with Doxil/Caelyx or Hycamtin in the intent-to-treat (ITT) populations. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Ovarian Neoplasms
- What is being tested?
- TLK286 HCl for injection, topotecan hydrochloride for injection and doxorubicin HCl liposome injection
- Type of treatment
- Injection or infusion
- How many people
- 440 participants
- Where
- 320 sitesin 13 countries
- Study dates
- Jun 2003to Dec 2006
- Phase
- Phase 3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Considered platinum refractory or resistant according to standard criteria
- Progressed during or following completion of one second-line treatment with Doxil/Caelyx or Hycamtin
- Histologically or cytologically confirmed diagnosis of epithelial cancer of the ovary, fallopian tube, or primary peritoneal cancer
- Measurable disease according to RECIST criteria with documented tumor progression
Who cannot join
- Treatment with second-line chemotherapy other than Doxil/Caelyx or Hycamtin
- History of whole pelvis radiation therapy within 12 months of enrollment
- Clinically significant cardiac disease
- Evidence of gross hematuria at the time of study entry
- Any signs of intestinal obstruction interfering with nutrition at the time of study entry
- Pregnant or lactating women
Trial locations and contacts
320 sites in 13 countries.
320 sites in 13 countries
United States234 sites
Western Washington Oncology
Aberdeen, Washington, 98520
Abington Mem. Hospita/Rosenfield Cancer Center
Abington, Pennsylvania, 19001
UNM Cancer Research and Treatment Center
Albuquerque, New Mexico, 87131
Amarillo Cancer Center
Amarillo, Texas, 79106
St. Joseph Mercy Hospital
Ann Arbor, Michigan, 48106
Arlington Cancer Center
Arlington, Texas, 76012
Benjamin Schwartz, M.D.
Babylon, New York, 11702
Southern California Permanente Medical Group
Baldwin Park, California, 91706
Sinai Cancer Institute
Baltimore, Maryland, 21205
North Shore Oncology Hematology Associates
Barrington, Illinois, 60010
MacNeal Cancer Center
Berwyn, Illinois, 60402
Center for Cancer and Blood Disorders
Bethesda, Maryland, 20817
Deaconess Billings Clinic
Billings, Montana, 59101
Hematology & Oncology Centers Northern Rockies
Billings, Montana, 59101
Mid Dakota Clinic
Bismarck, North Dakota, 58501
Odyssey Research Services
Bismarck, North Dakota, 58501
The Center for Hematology-Oncology
Boca Raton, Florida, 33486
St. Elizabeth's Med. Ctr.
Boston, Massachusetts, 02135
Providence Saint Joseph Medical Center
Burbank, California, 91505-4866
Hematology Oncology Centers of the Northern Rockies
Butte, Montana, 59701
Western Washington Oncology
Centralia, Washington, 98531
Carolina Center of Gynecologic Oncology, PA
Charleston, South Carolina, 29407
Blumenthal Cancer Center
Charlotte, North Carolina, 28203
Presbyterian Gynecologic Oncology
Charlotte, North Carolina, 28204
Presbyterian Hospital Center for Cancer Research
Charlotte, North Carolina, 28204
Chattanooga Oncology & Hematology Associates, P.C.
Chattanooga, Tennessee, 37404
Memorial Hospital
Chattanooga, Tennessee, 37404
Swedish Covenant Cancer Center
Chicago, Illinois, 60625
Hematology Oncology Associates of Illinois (HOAI)
Chicago, Illinois, 60657
Chippewa Falls Cancer Center
Chippewa Falls, Wisconsin, 54729
Marilyn Norton, M. D.
Chula Vista, California, 91911
Rosalba Rodriguez, M. D.
Chula Vista, California, 91911
Oncology/Hematology Care, Inc.
Cincinnati, Ohio, 45013
Barrett Cancer Center
Cincinnati, Ohio, 45219-0501
Barrett Cancer Center
Cincinnati, Ohio, 45219
Oncology/Hematology Care, Inc.
Cincinnati, Ohio, 45219
UC Physician's Medical Arts Bldg.
Cincinnati, Ohio, 45219
UC Physician's Medical Arts Building
Cincinnati, Ohio, 45219
University Hospital
Cincinnati, Ohio, 45219
Oncology/Hematology Care, Inc.
Cincinnati, Ohio, 45230
Oncology/Hematology Care, Inc.
Cincinnati, Ohio, 45236
Oncology/Hematology Care, Inc.
Cincinnati, Ohio, 45242
Metro Health Medical Center
Cleveland, Ohio, 44109
MetroHealth Medical Center
Cleveland, Ohio, 44109
Hematology Oncology Centers of the Northern Rockies
Cody, Wyoming, 82414
Ellis Fischel Cancer Center
Columbia, Missouri, 65203
South Carolina Oncology Associates, PA
Columbia, South Carolina, 29201
Mid-Ohio Oncology Hematology St. Anne's
Columbus, Ohio, 43081
Mid Ohio Oncology Hematology
Columbus, Ohio, 43213
Mid-Ohio Oncology Hematology
Columbus, Ohio, 43213
Gynecologic Oncology
Columbus, Ohio, 43222
Mount Carmel Health
Columbus, Ohio, 43222
Bay Area Research Cancer Group
Concord, California, 94520
The Mary Imogene Bassett Hospital
Cooperstown, New York, 13326
Hematology and Oncology Specialists, LLC
Covington, Louisiana, 70433
Covington Multicare - Oncology Clinic
Covington, Washington, 98042
Oncology/Hematology Care, Inc.
Crestview, Kentucky, 41017
Dallas Oncology Consultants
Dallas, Texas, 75201
Texas Cancer Associates
Dallas, Texas, 75231
Danville Hematology and Oncology, Inc.
Danville, Virginia, 24541
Wright State Univ. School of Medicine
Dayton, Ohio, 45409
Cancer Care Specialists of Central IL
Decatur, Illinois, 62526
Decatur Memorial Hospital
Decatur, Illinois, 62526
The Center for Hematology-Oncology
Delray Beach, Florida, 33484
Suburban Hematology Oncology
Duluth, Georgia, 30096
St. Mary's Duluth Clinic
Duluth, Minnesota, 55805
Advanced Imaging
Dunmore, Pennsylvania, 18512
Hematology & Oncology Associates of NEPA
Dunmore, Pennsylvania, 18512
Regional Cancer Center
Eau Claire, Wisconsin, 54701
Cancer Care Specialists of Central IL-Crossroads Cancer Care Center
Effingham, Illinois, 62401
Elkhart General Hospital
Elkhart, Indiana, 46514
Michiana Hematology Oncology
Elkhart, Indiana, 46514
Southwest Cancer Care
Escondido, California, 92025
Dakota Cancer Institute
Fargo, North Dakota, 58103
Odyssey Research Services
Fargo, North Dakota, 58104
Joliet Oncology-Hematology Associates, Ltd.
Flossmoor, Illinois, 60422
Texas Oncology, PA
Fort Worth, Texas, 76104
Southwest Fort Worth Cancer Center
Fort Worth, Texas, 76132
The Consultant Group
Franklin, Tennessee, 37067
California Oncology of the Central Valley
Fresno, California, 93710
The Sarah Cannon Cancer Center/Tennessee Oncology, PLLC
Gallatin, Tennessee, 37066
Gynecologic Oncology Research and Development
Greenville, South Carolina, 29605
Kaiser Permanente Oncology Clinical Trials Program
Hayward, California, 94545
The Sarah Cannon Cancer Center/Tennessee Oncology, PLLC
Hermitage, Tennessee, 37076
Memorial Regional Hospital
Hollywood, Florida, 33021
Sheridan Clinical Research, Inc.
Hollywood, Florida, 33021
Kaiser Permanente - Moanalua Medical Center
Honolulu, Hawaii, 96819
Straub Clinic and Hospital
Honolulu, Hawaii, 96826
Univ. of Hawaii, Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, 96826
Univ. of TX, MD Anderson Cancer Center
Houston, Texas, 77030
Indiana Cancer Pavilion
Indianapolis, Indiana, 46202
Indiana University Medical Center
Indianapolis, Indiana, 46202
St. Vincent Gynecologic Oncology
Indianapolis, Indiana, 46260
St. Vincent Hospital and Health Care Center
Indianapolis, Indiana, 46260
St. Vincent Hospital and Helath Care Center
Indianapolis, Indiana, 46260
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242
University of Iowa
Iowa City, Iowa, 52242
University of Florida Health Science Center/Jacksonville
Jacksonville, Florida, 32209
Joliet Oncology-Hematology Associates, Ltd.
Joliet, Illinois, 60435
Saint Mary's Health System, Inc.
Knoxville, Tennessee, 37917
Hall and Martin, M.D.'s, P.C.
Knoxville, Tennessee, 37920
Fort Sanders Parkwest Medical Center
Knoxville, Tennessee, 37923
Gynecologic Oncology Associates
La Jolla, California, 92037
Grossmont Hospital
La Mesa, California, 91942
Sharp Rees-Stealy
La Mesa, California, 91942
North Shore Oncology Hematology Associates - Deerpath Medical Associates
Lake Forest, Illinois, 60045
Sparrow Regional Cancer Center
Lansing, Michigan, 48909
Nevada Cancer Center
Las Vegas, Nevada, 89109
Suburban Hematology-Oncology Associates
Lawrenceville, Georgia, 30045
The Sarah Cannon Cancer Center/Tennessee Oncology, PLLC
Lebanon, Tennessee, 37087
North Shore Oncology Hematology Associates
Libertyville, Illinois, 60048
Little Rock Hematology Oncology Associates
Little Rock, Arkansas, 72205
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205
LLU Faculty Medical Offices
Loma Linda, California, 92354
LLU Faculty Meidical Offices
Loma Linda, California, 92354
Loma Linda University Medical Center
Loma Linda, California, 92354
David Geffen School of Medicine at UCLA
Los Angeles, California, 90095
Women's Cancer Center - Community Hospital Los Gatos
Los Gatos, California, 95032
Univ. of Louisville, Div. of Gynecologic Oncology
Louisville, Kentucky, 40202
Med-Onc/Hem
Malone, New York, 12953
Marshfield Clinic Research Foundation
Marshfield, Wisconsin, 54449
Saint Joseph's Hospital
Marshfield, Wisconsin, 54449
Wisconsin Rapid Cancer Center
Marshfield, Wisconsin, 54494
Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio, 44124
North Shore Oncology Hematology Associates
McHenry, Illinois, 60050
Merrill Cancer Center
Merrill, Wisconsin, 54452
OncRx (Pharmacy)
Metairie, Louisiana, 70002
Medical Consultants, Ltd.
Milwaukee, Wisconsin, 53215
Marshfield Clinc - Lakeland Center
Minocqua, Wisconsin, 54548
Marshfield Clinic - Lakeland Center
Minocqua, Wisconsin, 54548
Joliet Oncology-Hematology Associates, Ltd.
Morris, Illinois, 60450
The Sarah Cannon Cancer Center/Tennessee Oncology, PLLC
Murfreesboro, Tennessee, 37130
Southwest Cancer Care
Murrieta, California, 92562
The Sarah Cannon Cancer Center/Tennessee Oncology, PLLC
Nashville, Tennessee, 37203
The Consultant Group
Nashville, Tennessee, 37205
The Sarah Cannon Cancer Center/Tennessee Oncology, PLLC
Nashville, Tennessee, 37205
The Sarah Cannon Cancer Center/Tennessee Oncology, PLLC
Nashville, Tennessee, 37207
The Sarah Cannon Cancer Center/Tennessee Oncology, PLLC
Nashville, Tennessee, 37211
Jersey Shore University Medical Center
Neptune City, New Jersey, 07754
The Cancer Institute of New Jersey
New Brunswick, New Jersey, 08901
Robert Wood Johnson University Hospital
New Brunswick, New Jersey, 08903
Hematology-Oncology Associates of Rockland
New City, New York, 10956
Long Island Jewish Medical Center
New Hyde Park, New York, 11040
North Shore-Long Island Jewish Health System/Medical Center
New Hyde Park, New York, 11040
Hematology and Oncology Specialists, LLC
New Orleans, Louisiana, 70115
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121
Bellevue Hospital Center
New York, New York, 10016
Comprehensive Cancer Center Medical Practice Offices
New York, New York, 10016
New York University Medical Center - Tisch Hospital
New York, New York, 10016
NYU School of Medicine
New York, New York, 10016
Memorial Sloan Kettering Cancer Center
New York, New York, 11021
Gyncologic Oncology Associates
Newport Beach, California, 92663
Whittingham Cancer Center at Norwalk Hospital
Norwalk, Connecticut, 06856
The Union State Bank Cancer Center at Nyack Hospital
Nyack, New York, 10960
Kaiser Permanente Oncology Clinical Trials Program
Oakland, California, 94611
N. County Oncology Medical
Oceanside, California, 92056
OU Medical Center - Everett Tower
Oklahoma City, Oklahoma, 73104
OU Physicians' Bldg.
Oklahoma City, Oklahoma, 73104
Presbyterian
Oklahoma City, Oklahoma, 73104
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104
Western Washington Oncology
Olympia, Washington, 98502
Western Washington Oncology
Olympia, Washington, 98506
Florida Hospital
Orlando, Florida, 32803
Gynecologic Oncology
Orlando, Florida, 32804
Florida Hospital Memorial Division, Cancer Care Center
Ormond Beach, Florida, 32174
Florida Hospital Memorial Division
Ormond Beach, Florida, 32174
Palm Beach Cancer Institute
Palm Beach Gardens, Florida, 33410
Gynecologic Oncology Associates
Pembroke Pines, Florida, 33028
Magee-Womens Hospital
Pittsburgh, Pennsylvania, 15213
Hematology/Oncology Associates of Treasure Coast
Port Saint Lucie, Florida, 34952
Kaiser Permanente Nw, Oncology Research
Portland, Oregon, 97227
Oregon Health & Science University
Portland, Oregon, 97239-3098
Oregon Health Science University
Portland, Oregon, 97239
Southwest Cancer Care
Poway, California, 92064
Kaiser Permanente Oncology Clinical Trials Program
Redwood City, California, 94063
Diagnostic Radiology Associates
Rice Lake, Wisconsin, 54868
Lakeview Medical Center
Rice Lake, Wisconsin, 54868
Marshfield Clinic - Indianhead Center
Rice Lake, Wisconsin, 54868
Gynecologic-Oncology
Rochester, New York, 14620
Kaiser Permanente Oncology Clinical Trials Program
Roseville, California, 95661
Kaiser Permanente Oncology Clinical Trials Program
Sacramento, California, 95825
Southern California Permanente Medical Group
San Diego, California, 92120
Medical Oncology Associates-SD
San Diego, California, 92123
Sharp Healthcare Clinical Oncology Research
San Diego, California, 92123
Sharp Memorial Hospital
San Diego, California, 92123
Sharp Rees-Stealy
San Diego, California, 92123
Kaiser Permanente Oncology Clinical Trials Program
San Francisco, California, 94115
Kaiser Permanente Oncology Clinical Trials Program
San Rafael, California, 94903
Kaiser Permanente Oncology Clinical Trials Program
Santa Clara, California, 95051
Kaiser Permanente Oncology Clinical Trials Program
Santa Rosa, California, 95403
Kaiser Permanente Oncology Clinical Trails Program
Santa Teresa, California, 95119
Memorial Health University Medical Center
Savannah, Georgia, 31404
Horizon's West Medical Group
Scottsbluff, Nebraska, 69361
Viewmont Medical Services
Scranton, Pennsylvania, 18508
Community Medical Center
Scranton, Pennsylvania, 18510
Mercy Health Partners
Scranton, Pennsylvania, 18510
Moses Taylor Hospital
Scranton, Pennsylvania, 18510
Western Washington Oncology
Shelton, Washington, 98584
Hematology Oncology of the Northern Rockies
Sheridan, Wyoming, 82801
LSU Health Sciences Center
Shreveport, Louisiana, 71103
Sioux Valley Clinic Clinical Research Center
Sioux Falls, South Dakota, 57104
Sioux Valley Clinic Oncology
Sioux Falls, South Dakota, 57104
Sioux Valley Hospital - North Center Radiology
Sioux Falls, South Dakota, 57104
Sioux Calley Clinic OBGYN Ltd.
Sioux Falls, South Dakota, 57105
Hematology Oncology Associates of Illinois (HOAI)
Skokie, Illinois, 60076
Midwest Cancer Research Group, Inc.
Skokie, Illinois, 60077
The Sarah Cannon Cancer Center/Tennessee Oncology, PLLC
Smyma, Tennessee, 37167
Suburban Hematology Oncology
Snellville, Georgia, 30078
Michiana Hematology Oncology
South Bend, Indiana, 46617
St. Joseph's Regional
South Bend, Indiana, 46617
Saint Joseph's Regional
South Bend, Indiana, 46634
Women's Cancer Research Foundation, Inc.
South Miami, Florida, 33143
Kaiser Permanente Oncology Clinical Trials Program
South San Francisco, California, 94080
Gynecologic Oncology Research and Development
Spartanburg, South Carolina, 29303
St. Louis University, Dept. of Ob-Gyn and Women's Health
St Louis, Missouri, 63117
Gynecology & Oncology Consultants, PC
St Louis, Missouri, 63141
Saint John's Mercy Hospital
St Louis, Missouri, 63141
Hematology Oncology, P.C.
Stamford, Connecticut, 06902
Saint Michael Hospital
Stevens Point, Wisconsin, 54481
Allenmore Hospital - Hematology Oncology Clinic
Tacoma, Washington, 98405
MultiCare Health System - Medical Oncology
Tacoma, Washington, 98405
Associates in Hematology-Oncology, P.C.
Upland, Pennsylvania, 19013
Kaiser Permanente Oncology Clinical Trials Program
Vallejo, California, 94589
Kaiser Permanente Oncology Clinial Trials Program
Walnut Creek, California, 94596
Wausau Cancer Center
Wausau, Wisconsin, 54401
Palm Beach Cancer Institute
Wellington, Florida, 33414
Good Samaritan Hospital Medical Center
West Islip, New York, 11795
South Bay OB/GYN
West Islip, New York, 11795
Palm Beach Cancer Institute
West Palm Beach, Florida, 33401
Research Support Personnel, LLC
Wichita, Kansas, 67208
Associates in Women's Health
Wichita, Kansas, 67214
Piedmont Hematology Oncology Assoc., PA-Salem Research Group
Winston-Salem, North Carolina, 27103
Salem Research Group, Inc.
Winston-Salem, North Carolina, 27103
Wake Forest University School of Medicine
Winston-Salem, North Carolina, 27157
Argentina13 sites
Hospital Italiano Regional del Sur
Bahía Blanca, Buenos Aires, B8001HXM
Hospital Italiano de Buenos Aires
Buenos Aires, Buenos Aires, C1181ACH
Sanatorio Municipal Dr. Julio Mendez
Buenos Aires, Buenos Aires, C1405CNF
Hospital General de Agudos "Carlos G. Durand"
Buenos Aires, Buenos Aires, C1405DCS
Complejo Medico de la Policia Federal Argentina "Churruca-Visca"
Buenos Aires, Buenos Aires, C1437JCP
Hospital de Oncologia Maria Curie
Buenos Aires, Buenos Aires
Policlinica Privada Instituto de Medicina Nuclear
Buenos Aires, Buenos Aires
Hospital Donacion Francisco Santojanni
Buenos Aires, 1408
Complejo Medico de la Policia Federal Argentina "Churruca-Visca"
Buenos Aires, 1437
Hospital General de Agudos Donacion F. Santojanni
Capital Federal, Buenos Aires, 1408
Sociedad de Beneficencia Hospital Italiano
Córdoba
Hospital Universitario Austral
Pilar, Buenos Aires, B1629AHJ
ISIS Clinica Especializada
Santa Fe, Santa Fe Province, 03000
Brazil12 sites
Hospital de Clinicas de Porto Alegre
Bairro Bom Fim, Porto Alegre, 90035-003
Hospital Vera Cruz
Belo Horizonte, Minas Gerais, 30190-130
Hospital Luxemburgo
Belo Horizonte, Minas Gerais, 32380
Hospital de Clinicas da Universidade Federal do Parana
Curitiba, Paraná
Instituto do Cancer do Ceara
Fortaleza, Ceará, 60430-230
Centro de Tratamento Oncologico de Londrina
Londrina, Paraná, 86010-640
INCA Hospital de Oncologia Clinica
Rio de Janeiro, Rio de Janeiro, 20220-410
Instituto Arnaldo Vieira de Carvalho
São Paulo, São Paulo, 01223
Hospital do Cancer - A.C. Camargo
São Paulo, São Paulo, 01509
Unifesp/Epm
São Paulo, São Paulo, 04024-002
Hospital das Clinicas de Sao Paulo-FMUSP
São Paulo, São Paulo, 05403
Instituto de Saude e Bem Estar da Mulher
São Paulo, São Paulo
United Kingdom12 sites
St. Chad's Outpatients Unit, City Hospital
Birmingham, B18 7QH
United Bristol Healthcare Trust - Bristol Oncology Centre
Bristol, BS2 8ED
Beatson Oncology Centre
Glasgow, G11 6NT
Beatson Oncology Unit
Glasgow, G11 6NT
Medical Oncology - Guy's and St. Thomas' Hospital
London, SE1 9RT
Department of Medicine-Royal Marsden Hospital
London, SW3 6JJ
Department of Medical Oncology, Christie Hospital
Manchester, M20 4BX
Medical Oncology (NCCT) - Newcastle General Hospital
Newcastle upon Tyne, NE4 6BE
Dorset Cancer Centre - Poole Hospital
Poole, BH15 2JB
Department of Cancer Medicine - Ninewells Hospital & Medical School
Scotland, Dundee, DD1 9SY
Dept. of Med. Oncology/The Royal Marsden Hospital
Sutton, Surrey, SMT 5PT
Velindre NHS Trust - Velindre Hospital
Wales, CFT142TL
Czechia8 sites
Masarykuv Onkologicky Ustav
Brno, 656 53
Fakultni Nemocnice - Onkologicka Klinika
Doudlevecka 69, Plzen, 301 31
Batova krajska nemocnice Zlin, prispevkova organizace, Radiodiagnosticke oddeleni
Havlickovo Nabrezi, Zlín, 76001
Batova krajska nemocnice Zlin, prispevkova organizace, Onkologicke oddeleni
Havlickovo Nabrezi 600, Zlín, 76001
Krajska nemocnice Pardubice, Oddeleni radiacni onklogie
Kyjevska 44, Pardubice, 53203
Fakultni nemocnice Olomouc, Onkologicka klinika
Pardubice, Olomouc, 77520
Fakultni nemocnice, Onkologicka klinika
Pilsen
Vseobecna Fakultni Nemocnice - Onkologicka Klinika
Unemocnice, Prague, 12808
Germany8 sites
Universitatsklinikum Charite - Campus Virchow-Klinikum
Berlin, D13353
St. Vincentius Kliniken
Karlsruhe, D-76137
St. Vincentius Kliniken - Frauenkinik
Karlsruhe, D76137
St. Vincentius Kliniken - Radiology
Karlsruhe, D76137
Klinikum GroBhadern-Institut fur Radiologie
Munich, D-81377
Klinikum GroBhadern-Zentrum fur Frauenheilkunde
Munich, D81377
Universitaets-Frauenklinik Ulm
Ulm, D89075
Dr. Horst-Schmidt-Kliniken GmbH
Wiesbaden, D65199
Spain8 sites
Hospital Clinic i Provincial de Barcelona - Servicio de Oncologia Medica
Barcelona, 08036
Hospital Clinic i Provincial
Barcelona, 8035
Hospital General de Guadalajara
Guadalajara
Servicio de Oncologia
Madrid, 28007
Instituto Valenciano de Oncologia (IVO)
Profesor Beltran Baguena, Valencia, 46009
Instituto Valenciano de Oncologia (IVO) Servicio de Oncologia
Valencia, 46009
Instituto Valenciano de Oncologia (IVO) Servicio de Radiologia
Valencia, 46009
Servicio Oncologia Hospital General Vall d'HebronPaseo
Vall d'Hebron, Barcelona, 119-129
Belgium7 sites
AZ-VUB Dienst Oncologie
Brussels, 1090
Cliniques Universitaires Saint-Luc
Brussels, B 1200
Universitair Ziekenhuis Gent.
Ghent, 9000
University Hospital Gasthuisberg
Herestraat, Leuven, 49
Centre Hospitalier Regional de la Citadelle
Liège, 4000
Algemeen Ziekenhuis Antwerpen
Lindedreef, Antwerpen, 2020
Universitaire Ziekenhuis Antwerpen
Wilrijkstraat, Edegem, 2650
Hungary7 sites
Semmelweis University, 1st Dept. of Obstetrics and Gynaecology
Baross, H-1088
Uzsoki Street Hospital Dept. of Radiooncology
Budapest, H-1145
Faculty of Gynaecologycal Oncology/Univ. of Debrecen
Debrecen, 4032
Baranya County Hospital
Pécs, 7632
Baranya County Hospital - Department of Oncology
Rakoczi
Baranya County Hospital - Department of Radiology
Rakoczi
SZTE, Department of Oncotherapy
Szeged, 6720
South Africa6 sites
Wilgers Oncology Centre
Die Wilgers X14, Pretoria, 41
Hopelands Cancer Centre
Overport, Durban, 4091
Panorama Medical Centre
Panorama, Cape Town, 7500
Eastern Cape Oncology Research Centre
Port Elizabeth, 6001
Medical and Dental Centre
Rosebank, Johannesburg, 2196
Rosebank Oncology Centre
Saxonwold, Johannesburg, 2196
Chile2 sites
Servicio de Oncologia-Hospital Clinico Unversidad de Chile
Independencia, Santiago Metropolitan, Santos Dumontt 999
Clinica Santa Maria
Santiago, Santiago de Chile
Netherlands2 sites
Vrije Universiteit Medical Centre (VUMC)
HV Amsterdam, 1081
University Medical Centre Nijmegen (UMCN)
Nijmegen, 6525
Ireland1 site
Oncology Dept., University Floor, Belfast City Hospital
Belfast, BT9 7AB
About this study
Official title: Phase 3 Randomized Study of TLK286 (Telcyta) Versus Doxil/Caelyx or Hycamtin as Third-Line Therapy in Platinum Refractory or Resistant Ovarian Cancer [ASSIST-1 (Assessment of Survival In Solid Tumors-1)]
The purpose of this study is to demonstrate superiority in survival in favor of TLK286 as compared to active control therapy with Doxil/Caelyx or Hycamtin in the intent-to-treat (ITT) populations.
- Conditions
- Ovarian Neoplasms
- Being tested
- TLK286 HCl for injection, topotecan hydrochloride for injection, doxorubicin HCl liposome injection
- Keywords
- ovary
- Medical subject headings
- Ovarian Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TLK286 HCl for injectionDrug
topotecan hydrochloride for injectionDrug
doxorubicin HCl liposome injectionDrug
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Apr 2003 (estimated)
- Study startJun 2003
- Primary completionDec 2006
- Study completionDec 2006
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Ovarian NeoplasmsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Masking
- None (open label)
- Enrolment
- 440 participants
Sponsor and investigators
- Lead sponsor
- Telik
- Sponsor type
- Industry (pharma, biotech, devices)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00057720
- Sponsor's protocol ID
- TLK286.3017
- Status last verified
- May 2006
- First submitted
- 7 Apr 2003
- Last updated
- 25 Jul 2011
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Jul 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Phase 3 Randomized Study of TLK286 (Telcyta) Versus Doxil/Caelyx or Hycamtin as Third-Line Therapy in Platinum Refractory or Resistant Ovarian Cancer [ASSIST-1 (Assessment of Survival In Solid Tumors-1)]
- ClinicalTrials.gov ID
- NCT00057720
- Acronym / sponsor ID
- TLK286.3017
- Conditions
- Ovarian Neoplasms
- Keywords
- ovary
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 440 participants
- Lead sponsor
- TelikIndustry (pharma, biotech, devices)
- Study start
- Jun 2003
- Primary completion
- Dec 2006 (actual)
- Study completion
- Dec 2006 (actual)
- First posted
- 8 Apr 2003 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to demonstrate superiority in survival in favor of TLK286 as compared to active control therapy with Doxil/Caelyx or Hycamtin in the intent-to-treat (ITT) populations.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Masking
- None (open label)
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Considered platinum refractory or resistant according to standard criteria
- Progressed during or following completion of one second-line treatment with Doxil/Caelyx or Hycamtin
- Histologically or cytologically confirmed diagnosis of epithelial cancer of the ovary, fallopian tube, or primary peritoneal cancer
- Measurable disease according to RECIST criteria with documented tumor progression
Key exclusion criteria (6 listed)
- Treatment with second-line chemotherapy other than Doxil/Caelyx or Hycamtin
- History of whole pelvis radiation therapy within 12 months of enrollment
- Clinically significant cardiac disease
- Evidence of gross hematuria at the time of study entry
- Any signs of intestinal obstruction interfering with nutrition at the time of study entry
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TLK286 HCl for injection | Drug | – |
| topotecan hydrochloride for injection | Drug | – |
| doxorubicin HCl liposome injection | Drug | – |
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Jul 2011.
Related trials for Ovarian Neoplasms
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
RecruitingPhase 2
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Ovarian Cancer, Fallopian Tube Cancer
Active, not recruitingPhase 1/2
Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...
Colorectal Neoplasms, Breast Neoplasms
Recruiting
The Vanguard Study: Testing a New Way to Screen for Cancer
Bladder Carcinoma, Breast Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
320 sites in 13 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing TLK286 HCl for injection, topotecan hydrochloride for injection and doxorubicin HCl liposome injection in people with Ovarian Neoplasms, run by Telik at 320 sites in 13 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Jul 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 320 sites in United States, Argentina, Brazil, United Kingdom, Czechia and 8 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2011.